I am very aware of the hon. Lady's work as chair of the APPG, so I am not surprised that she asks about that important issue, which she has been assiduous in raising. I will flag up the follow-up with my ministerial colleague. I draw the hon. Lady's attention to the fact that the National Institute for Health and Care Research remains open to research proposals in this area.

We are always happy to assist colleagues across the United Kingdom as part of our commitment to the Union. My hon. Friend is right to highlight current performance in Wales. As I have said, patients are waiting twice as long for hospital treatment in Wales as in England, and more than 50,000 people in Wales are waiting for more than two years for their operation.

What the hon. Gentleman omits to remind the House is that at the time the demand from trade unions was for a 19% consolidated pay rise, which is very different from the basis on which talks have been entered into. The point is that we are in discussions with trade union colleagues.

I have come to the House literally from a meeting with the trade unions: I met the NHS Staff Council this morning. Once again, hon. Members on the Opposition Front Bench are writing their questions before they see what is actually happening.

I thank my hon. Friend for raising this important issue. We are launching a prevention of suicide strategy, and male suicide will be a particular focus, as it is a high-risk group. The debate next week will be answered by a Minister in the Department for Education, because it relates specifically to the national curriculum, but I am very happy to meet my hon. Friend and his constituent.

Sun exposure is one of the most significant causes of cancer. That is one reason why we are working so hard with the NHS to reduce backlogs for people who are waiting for cancer diagnosis and treatment, including by rolling out teledermatology across the NHS to reduce diagnosis times. However, the hon. Gentleman's question about VAT and skin cancer is a matter for the Treasury.

As we heard earlier from the Parliamentary Under-Secretary of State, my hon. Friend the Member for Harborough (Neil O'Brien), the major conditions strategy report will deal with those issues. However, it is also important to consider the variation in performance between integrated care boards and how we can raise the bottom quartile to the level of the top quartile—there is far too much variation within the NHS—and to be data-driven, so that when it comes to genomics and screening we can target the outliers more precisely. That is what is behind the issue to which my hon. Friend has rightly drawn attention.

Cancer will be a substantial part of the major conditions strategy. We will be looking at the major causes of ill health in the country, of which cancer is, of course, one. Part of that will involve ensuring that we are good at diagnosing cancer, because the earlier it is diagnosed, the more treatable it is, and hence the better the outcomes for people with cancer will be.

We will be setting out our next steps on smoking shortly, but we already have the lowest smoking level on record: it has fallen to 13%, partly as a result of the doubling of duty on cigarettes and partly owing to the introduction of a minimum excise tax. We will be investing £35 million in the NHS this year to ensure that all smokers who are admitted to hospital are given NHS-funded tobacco treatment.

It is indeed a worrying experience for people to be waiting to know whether they have cancer or, having received a diagnosis, to be waiting for treatment. However, I can assure the hon. Gentleman that more people are currently coming forward for cancer checks, more people are being treated for cancer, and the NHS is reducing some of the backlogs following the pandemic.

My right hon. Friend's question was so good that I was eager to answer it early. He is right to highlight this issue, which is being dealt with as part of a wider thrust within Government work on prevention, which is how we can empower the patient. That means getting more data to patients and using genomics and screening to ensure that they are better informed and can therefore opt to take decisions on healthy eating, rather than the state trying to impose those decisions on them in a top-down manner.

I am happy for a member of the ministerial team to meet the hon. Lady, who has made a compelling case about the return on investment. We will obviously need to scrutinise it in more detail, and I am sure that my colleagues will look forward to doing so.

My hon. Friend is right to highlight the issues in Medway and those in Kent as a whole. When I met the chief executive of Maidstone Hospital yesterday, we discussed some of the innovation that it has introduced and the benefits of that innovation across the board. As for the new hospitals programme, I remind my hon. Friend of the comments made by my right hon. Friend the Prime Minister on 22 February, when he confirmed the Government's commitment to that programme.

The hon. Gentleman will know that we have huge sympathy for those affected by Primodos. He will also know that there is a legal case at the moment so I am unable comment at this time, but I am happy to discuss it with him further.

My hon. Friend is right to highlight the community services that we are doing as part of our urgent and emergency recovery plan, looking at how we deliver care quicker through innovative models. One of those involves better cooperation with the fire service.

We will be setting out further steps shortly, but there are 6.5% more dentists doing work for the NHS than in 2010 and we have started the reforms with more units of dental activity bands and a minimum UDA.

My hon. Friend is right to highlight the fact that a number of services that GPs currently offer could be performed by pharmacists, and we are looking at that in the context of the primary care recovery plan. This is also about looking at how we can relieve some of the workload pressure within primary care, and that is why we have recruited 25,000 additional staff to support GPs.

That is exactly why we are spending £55 billion this winter to help households and businesses with their energy bills. That is one of the largest support packages in Europe.

It is for schemes such as those that my hon. Friend highlights that we are investing a further £2.3 billion a year in mental health services, and that in turn is facilitating an extra 2 million patients accessing NHS-funded mental health support.

That is exactly why we will continue to reform the contract as the hon. Lady suggests, and it is why we have started allowing dentists to do 110% of their UDAs, but she is right and we will go further.

My hon. Friend is right to draw the House's attention to the extremely important work of hospices and to the fact that commissioning decisions are devolved to the integrated care boards so that they can target funding in the way that best serves local communities.